Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114
Jordan, Jens, El-Armouche, Ali, Hanefeld, Markolf, Bornstein, Stefan R., Birkenfeld, Andreas L.Volume:
39
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc16-1588
Date:
December, 2016
File:
PDF, 603 KB
english, 2016